Andexanet alfa and 4F-PCC use in patients hospitalised with an anticoagulant-related major bleed

Trial Identifier:	D9603R00004
Sponsor:	AstraZeneca
Collaborator:	Outcomes Insights
NCTID::	NCT05548777
Start Date:	September 2022
Primary Completion Date:	December 2022
Study Completion Date:	December 2022

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
US, California	Agoura Hills, California, US, 91301

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.